Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Diabetes

Diabetes for November/December 2015

FDA Approves Basaglar Injection for Diabetes , Approval granted via abbreviated pathway

Testing and Treating Patients With Diabetes, Study finds that many clinicians are overdoing it

Lifestyle Intervention and Gestational Diabetes , Effect on weight and physical activity evaluated

Testosterone Therapy and Hypogonadism , Effect on insulin sensitivity, lean mass and fat

Stress, Depression in Individuals With Diabetes, Odds of stroke and CV-related death evaluated

More must reads

Diabetes for September/October 2015

USPSTF Updates Guidelines on Screening for Diabetes , What they suggest for overweight/obese individuals

Wine’s Effect on Individuals With Diabetes, Improvement seen in these areas

Type 2 Diabetes and CVD Risk, Does ovarian hyperandrogenemia play a role?

Predicting Healing in Diabetic Foot Ulcers, Look for these factors revealed by assays

CIMT-Vascular Risk Link Seen in Diabetes, But..., ...no association seen when CIMT change evaluated

More must reads

Diabetes for July/August 2015

FDA Approves First Fully Mobile Continuous Glucose Monitor, Upgrade allows for data transmission to smartphones

Sweetened Beverages and Type 2 Diabetes, Connection explored and population impact estimated

Liraglutide’s Effect on Weight Loss, Trial compares different doses to placebo

New ADA/AHA Guideline on Preventing CVD in Diabetes Patients, Obesity, BP, and other recommendations updated

Adding Inhaled Insulin to Oral Meds, Its value in lowering HbA1c level explored

More must reads

Diabetes for May/June 2015

Room for Improvement in T1DM Care, Update from the T1D Exchange

Family Therapy Improves Diabetes Outcomes in Teens, Better control, ease of depression, and better family functioning

Exercising with Type 1 Diabetes, Weighing the benefits and risks

FDA Approves Humalog U-200 KwikPen, New 200 units/mL formulation only available in prefilled pen

More must reads

Diabetes for March/April 2015

FDA Approves U-300 Basal Insulin Pens, Long-acting Toujeo to be available in prefilled pens

More must reads

Pages